Advisory Panel for ICTP 2017
OCM Member
Professor, Ecological Engineering
Klaipeda University , Lithuania
Biography :

Olga Anne has completed her PhD at the age of 37 years from Moscow Chemical Technological University, Russian. She is the senior researcher/professor of Klaipeda University, Lithuania. She has over 60 publications in pre-reviewed journals and 17of them are in ISI WOS journals that have been cited over 45 times.

Research Interest :

Ecological Engineering, Biosystems Engineering, Bioengineering

OCM Member
Professor, Department of Medical and Surgical Sciences
University “Magna Græcia” of Catanzaro , Italy
Biography :

My research activity and scientific production primarily deal with the pathobiology of several respiratory disorders such as asthma, COPD, interstitial pulmonary diseases and lung cancer, and also regard the molecular mechanisms underlying the therapeutic actions of the main drugs used for their treatments. In particular, my current studies are focusing on the role of “mitogen-activated protein kinases” in the signal transduction pathways activated by cytokines, growth factors and oxidative stress in primary cultures of human pulmonary endothelial cells, bronchial epithelial cells, lung cancer cell lines, and pulmonary fibroblasts. A major research interest concerns the activation and inhibition of these enzymes in cell death and proliferation, as well as in development and pharmacological modulation of lung inflammation and remodelling. I am also particularly interested in the recent advances referring to the biological therapies of asthma, with special regard to anti-IgE treatment, with whom I am familiar since ten years ago. I have been actively involved in many basic studies and clinical trials, among which the most relevant include: (i) “Role of signal transduction pathways activated by oxidative stress or proliferative stimuli in the development and progression of lung cancer: possible diagnostic, prognostic, therapeutic and preventive implications”, financed by a grant of the Italian Ministry for University and Scientific Research (n. 2003061034 – years 2003-2004); (ii) International study “CIGE025A2425”, financed by Novartis and aimed to evaluate the clinical effects in severe, uncontrolled allergic asthma, of the humanized anti-IgE monoclonal antibody omalizumab (years 2005-2006); (iii) A Pan-European open randomised study comparing the efficacy and cost-effectiveness of Symbicort Maintenance and Reliever Therapy – Symbicort SMART – using a maintenance dose of Symbicort 160/4.5 ?g, 1 or 2 inhalations twice daily in the treatment of persistent asthma – EUROSMART (D5890L00022 – years 2007-2008). I conducted clinical research according to GCP. My scientific production comprehensively includes over 100 book chapters, reviews and original articles published in both national and international, peer-reviewed journals.

Research Interest :

pathobiology of several respiratory disorders such as asthma, COPD, interstitial pulmonary diseases and lung cancer, and also regard the molecular mechanisms underlying the therapeutic actions of the main drugs used for their treatments

OCM Member
Professor, Department of Genetics & Genome Biology
University of Leicester , United Kingdom
Biography :

Yuri E Dubrova was born in Kiev and spent his school years there. He obtained a BSc degree in Biology at Kiev State University and a PhD in Genetics at N.I. Vavilov Institute of General Genetics in Moscow. He then undertook a number of research projects in population genetics there. In 1994 he moved to the Department of Genetics University of Leicester to study the genetic effects of exposure to ionising radiation and chemical mutagens in mammals. Working there, he has developed a number of sensitive approaches for monitoring mutation induction in the mammalian germline. Analysing mutation rates at minisatellite loci in four cohorts of irradiated families from Belarus, Ukraine, Kazakhstan and Russia he obtained the first experimental evidence for radiation-induction of human germline mutation. Using another class of tandem repeat DNA loci, he analysed the pattern of mutation induction in the germline of male mice exposed to a variety of mutagens, including ionising radiation, alkylating agents and anticancer drugs. He has recently analysed the genome-wide effects of exposure to ionising radiation on mutation induction in the mouse germline.

Research Interest :

Analysis of Germline Mutation Induction in Humans and Mice Following Exposure to Ionising Radiation, Chemical Mutagens and Some Anticancer Drugs

OCM Member
Head of the Department, Institute of Pharmacochemistry
Tbilisi State Medical University , Georgia
Biography :

Dr. Karen G.Mulkijanyan currently holds positions of Head of the Department of Preclinical Pharmacological Research at Tbilisi State Medical University (TSMU) I.Kutateladze Institute of Pharmacochemistry and full Professor at the Caucasus International University Faculty of Medicine. He obtained MS in Biochemistry in 1981, and PhD in Pharmacy in 2005. Dr. Mulkijanyan was a manager/ key investigator of research projects funded by CRDF Global/GRDF, STCU, GNSF/SRSNF. As Organizing Committee Member, he arranged several international congresses and conferences on pharmacology and pharmacy. Dr. K.Mulkijanyan co-authored more than 100 scientific publications, 30 presentations at international scientific meetings and 2 patents in pharmacology. Dr. K.Mulkijanyan is Founder and President of the Georgian Association for Laboratory Animal Science, a member of the Association of Professional Chemists of Georgia and Association of University Technology Managers.

Research Interest :

Pharmacology of anti-inflammatory, ulcer preventive, burn and wound healing drugs; analysis of structure-activity relationship (SAR) and prediction of bioactivity of natural, modified and synthesized compounds; intellectual property protection; technology transfer and technology commercialization, use and care of laboratory animals.

OCM Member
Professor, Department of Toxicology & Pharmacology
Tehran University of Medical Sciences , Iran
Biography :

Omid Sabzevari (OS) is a scientist in the field of Mechanistic Toxicology and Pharmacology, Xenobiotics Analysis and Food Safety. OS was listed among Top 1% Scientists of the World according to ESI/ISI in May 2012. OS is a Temporary Adviser of WHO and a scientific member of the Expert Panel on Food Safety, JECFA. OS is President of Iranian Association of Pharmaceutical Scientists (IranAPS) and President of Iranian Society of Toxicology (IranTox). He is also the Head of Basic and Clinical Toxicology Research Centre, TUMS.

Mail us at

For Program Enquiry
toxicology@alliedconferences.org
To Secure your slot
toxicology@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact
toxicology@alliedconferences.org
to request a personalized letter of invitation.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to contact@alliedacademies.com

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to contact@alliedacademies.com . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference. The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  1. Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  2. Within 60-30 days of Conference: Eligible for 50% of payment Refund
  3. Within 30 days of Conference: Not eligible for Refund
  4. E-Poster Payments will not be refunded

Accommodation Cancellation Policy

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.
Copyright © 2017-2018 Allied Academies, All Rights Reserved.